Stock Track | AtriCure Soars 7.67% in Pre-market Following Strong Q4 Earnings Beat and Positive Analyst Outlook

Stock Track

Feb 18

AtriCure's stock surged 7.67% in pre-market trading on Wednesday, extending gains from the previous session.

The significant upward movement follows the surgical treatment innovator's release of fourth-quarter 2025 financial results that substantially exceeded analyst expectations. The company reported adjusted earnings per share of $0.06 against an expected loss, alongside strong revenue and EBITDA performance.

Positive analyst sentiment contributed to the pre-market momentum, with BTIG maintaining a Buy rating and $54 price target on the stock, citing sustained outperformance and undervalued growth potential. This supportive outlook comes alongside the company's optimistic 2026 guidance projecting continued revenue growth and positive cash generation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1153387633"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153387633\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153387633?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-18 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153387633","market":"nz","top_or_hot":-1,"title":"Stock Track | AtriCure Soars 7.67% in Pre-market Following Strong Q4 Earnings Beat and Positive Analyst Outlook","media":"Stock Track","content":"<p>AtriCure's stock surged 7.67% in pre-market trading on Wednesday, extending gains from the previous session.</p><p>The significant upward movement follows the surgical treatment innovator's release of fourth-quarter 2025 financial results that substantially exceeded analyst expectations. The company reported adjusted earnings per share of $0.06 against an expected loss, alongside strong revenue and EBITDA performance.</p><p>Positive analyst sentiment contributed to the pre-market momentum, with BTIG maintaining a Buy rating and $54 price target on the stock, citing sustained outperformance and undervalued growth potential. This supportive outlook comes alongside the company's optimistic 2026 guidance projecting continued revenue growth and positive cash generation.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AtriCure Soars 7.67% in Pre-market Following Strong Q4 Earnings Beat and Positive Analyst Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AtriCure Soars 7.67% in Pre-market Following Strong Q4 Earnings Beat and Positive Analyst Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-18 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AtriCure's stock surged 7.67% in pre-market trading on Wednesday, extending gains from the previous session.</p><p>The significant upward movement follows the surgical treatment innovator's release of fourth-quarter 2025 financial results that substantially exceeded analyst expectations. The company reported adjusted earnings per share of $0.06 against an expected loss, alongside strong revenue and EBITDA performance.</p><p>Positive analyst sentiment contributed to the pre-market momentum, with BTIG maintaining a Buy rating and $54 price target on the stock, citing sustained outperformance and undervalued growth potential. This supportive outlook comes alongside the company's optimistic 2026 guidance projecting continued revenue growth and positive cash generation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATRC","symbol_name":"AtriCure公司","start_time":0,"source_url":"","article_id":"1153387633","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153387633","pubTimestamp":1771416156,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"AtriCure's stock surged 7.67% in pre-market trading on Wednesday, extending gains from the previous session.The significant upward movement follows the surgical treatment innovator's release of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATRC":"AtriCure公司"},"translate_title":"股票追踪|AtriCure盘前飙升7.67%，此前第四季度盈利强劲，分析师前景乐观","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATRC":1},"content_text":"AtriCure's stock surged 7.67% in pre-market trading on Wednesday, extending gains from the previous session.The significant upward movement follows the surgical treatment innovator's release of fourth-quarter 2025 financial results that substantially exceeded analyst expectations. The company reported adjusted earnings per share of $0.06 against an expected loss, alongside strong revenue and EBITDA performance.Positive analyst sentiment contributed to the pre-market momentum, with BTIG maintaining a Buy rating and $54 price target on the stock, citing sustained outperformance and undervalued growth potential. This supportive outlook comes alongside the company's optimistic 2026 guidance projecting continued revenue growth and positive cash generation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}